The relative proportions of sirolimus metabolites in blood using HPLC with mass-spectrometric detection.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Transplantation Proceedings

• Publication date

  2004-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.TRANSPROCEED.2004.12.005PMID 15686732
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic monitoring of sirolimus: its contribution to optimal prescription.

  2003cited by this paper
• Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus.

  2000cited by this paper
• An immunoassay for the measurement of sirolimus.

  2000cited by this paper
• Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by HPLC/electrospray-mass spectrometry.

  1996cited by this paper

• Comparison of whole-blood sirolimus concentrations measured by EMIT-based Siemens Viva-ProE® System and LC-MS/MS in Chinese transplant patients.

  2024cites this paper
• Successful management of sirolimus toxicity in a hematopoietic stem cell transplant patient using automated red blood cell exchange

  2020cites this paper
• Therapeutic drug monitoring of immunosuppressants

  2020cites this paper
• Antineoplastic drugs and their analysis: a state of the art review.

  2017cites this paper
• Clinical laboratory diagnostics of immunosuppressants: One laboratory’s journey

  2015cites this paper
• Automated red blood cell exchange for acute drug removal in a patient with sirolimus toxicity

  2015cites this paper
• Long‐term evaluation of analytical methods used in sirolimus therapeutic drug monitoring

  2014cites this paper
• Immunosuppressive Drug Monitoring: Limitations of Immunoassays and the Application of Liquid Chromatography Mass Spectrometry

  2012cites this paper
• An accurate quantitative LC/ESI-MS/MS method for sirolimus in human whole blood.

  2011cites this paper
• Evaluation of QMS Everolimus Assay Using Hitachi 917 Analyzer: Comparison With Liquid Chromatography/Mass Spectrometry

  2011cites this paper
• Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer.

  2009cites this paper
• Characterization of sirolimus metabolites in pediatric solid organ transplant recipients

  2009influential citation
• Immunosuppressive Drugs: Pharmacokinetics, Preanalytic Variables, and Analytical Considerations

  2008cites this paper
• Crossreactivity of Isolated Everolimus Metabolites With the Innofluor Certican Immunoassay for Therapeutic Drug Monitoring of Everolimus

  2007cites this paper
• Comparison of the CEDIA and MEIA assays for the measurement of sirolimus in organ transplant recipients.

  2007cites this paper
• Identification of Everolimus Metabolite Patterns in Trough Blood Samples of Kidney Transplant Patients

  2007cites this paper
• Comparación de la cromatografía líquida de alta resolución frente al enzimoinmunoensayo de micropartículas para la determinación de sirolimus en trasplante renal

  2006cites this paper
• [Comparison of high-resolution liquid chromatography versus microparticle enzyme immunoassay for the measurement of sirolimus levels in renal transplantation].

  2006cites this paper
• Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus.

  2006cites this paper
• Evaluation of a microparticle enzyme immunoassay for the measurement of sirolimus in whole blood (Abbott IMx sirolimus).

  2006cites this paper
• A microparticle enzyme immunoassay to measure sirolimus.

  2004cites this paper